Shantha Raju

About Shantha Raju

Innovative R&D executive with expertise in both early– and late-stage biotherapeutics development and advancing highly effective discovery programs in aggressive entrepreneurial companies. PhD in Bio-organic Chemistry with a successful record in bioanalytical methods development from discovery research to licensing in multiple therapeutic areas. More than 25 years of experience in biological and small molecule drug development, including mAbs, ADCs, CARTs, gene therapy oncolytic virus vaccines and AAVs. Expertise in structure-activity relationship (SAR) studies, translational science, early and late stage clinical development along with clinical biomarkers strategies. Strong regulatory background, with IND and BLA expertise, including authoring CMC sections of IND and BLAA applications. Skilled at outsourcing and integrating external experts and resources with focused internal R&D teams, including management of CRO and CMO projects. US patents (all with foreign equivalents), author of a book, 48 peer-reviewed scholarly publications, and more than 150 scholarly presentations. Excellent written and verbal communication skills with strong leadership and interpersonal abilities.Author of Book entitled \"Co- and Post-translational Modifications of Therapeutic Antibodies and Proteins\" published by Wiley

Experience

1. Head of Astq

   Immodulon Therapeutics Ltd

   May 2023 — Present

   Leading ASTQ team activities and managing CRO activities along with testing services. Helping with the corporate goal of transitioning the project from Phase 2 to Phase 3. Designing a new MOA based potency assay for the product.

Education

• University of Mysore

  M.Sc., Chemistry/Biochemistry

• University of Mysore

  Ph.D., Chemistry/Biochemistry

• University of Mysore

  B. Sc., Physics, Chemistry and Mathematics